Last reviewed · How we verify
Pangramin Plus D. pteronyssinus — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Pangramin Plus D. pteronyssinus (Pangramin Plus D. pteronyssinus) — Miguel Blanca Gomez.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pangramin Plus D. pteronyssinus TARGET | Pangramin Plus D. pteronyssinus | Miguel Blanca Gomez | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pangramin Plus D. pteronyssinus CI watch — RSS
- Pangramin Plus D. pteronyssinus CI watch — Atom
- Pangramin Plus D. pteronyssinus CI watch — JSON
- Pangramin Plus D. pteronyssinus alone — RSS
Cite this brief
Drug Landscape (2026). Pangramin Plus D. pteronyssinus — Competitive Intelligence Brief. https://druglandscape.com/ci/pangramin-plus-d-pteronyssinus. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing